Quantum Biopharma Class B Subordinate Voting Shares
QNTM
9 hedge funds and large institutions have $256K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
34% more capital invested
Capital invested by funds: $192K → $256K (+$64.4K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.06% less ownership
Funds ownership: 3.7% → 3.63% (-0.06%)
25% less funds holding
Funds holding: 12 → 9 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$202K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.28K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$66 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$46K |
| 2 |
HF
HRT Financial
New York
|
-$40K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$184 |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$66 |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $254K | +$202K | +42,845 | +163% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.28K | +272 | +254% |
|
|
3
Group One Trading
Chicago,
Illinois
| $489 | -$184 | -39 | -23% |
|
|
SS
4
SBI Securities
Tokyo,
Japan
| $368 | +$471 | +100 | New |
|
|
5
National Bank of Canada
Montreal,
Quebec, Canada
| $123 | -$66 | -14 | -29% |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $101 | +$66 | +14 | +100% |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $55 | – | – | – |
|
|
AWM
8
Avior Wealth Management
Omaha,
Nebraska
| $11 | – | – | – |
|
|
TWC
9
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $7 | -$5 | -1 | -33% |
|
|
VF
10
Virtu Financial
New York
| – | -$46K | -11,428 | Closed |
|
|
HF
11
HRT Financial
New York
| – | -$40K | -10,041 | Closed |
|
12
Bank of America
Charlotte,
North Carolina
| – | -$4 | -1 | Closed |
|
13
Fidelity Investments
Boston,
Massachusetts
| – | -$4 | -1 | Closed |
|
QNTM Hedge Fund Activity: Q4 2024 in Review
9 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q4 2024, worth a combined $256K — up 34% from $192K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of QNTM and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was AdvisorShares Investments, adding an estimated $202K. The largest seller was Virtu Financial, exiting entirely with an estimated $46K sold.
- 9 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q4 2024, down from 12 in Q3 2024.
- Funds reported $256K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q4 2024, up 34% quarter-over-quarter.
- 1 fund opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q4 2024 and 4 closed out, a net change of -3 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q4 2024 was AdvisorShares Investments, an estimated $202K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q4 2024 was Virtu Financial, an estimated $46K sold.
Based on aggregated 13F filings for Q4 2024.